# Single-Dose Bioequivalence Study Comparing Two 4 mg Nicotine Lozenges

> **NCT03432312** · PHASE1 · COMPLETED · sponsor: **Fertin Pharma A/S** · enrollment: 42 (actual)

## Conditions studied

- Smoking Cessation

## Interventions

- **DRUG:** Nicotine lozenge
- **DRUG:** Nicotine lozenge

## Key facts

- **NCT ID:** NCT03432312
- **Lead sponsor:** Fertin Pharma A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-15
- **Primary completion:** 2018-02-17
- **Final completion:** 2018-02-17
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2018-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03432312

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03432312, "Single-Dose Bioequivalence Study Comparing Two 4 mg Nicotine Lozenges". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT03432312. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*